These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32031201)

  • 1. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
    Zou J; Chen S; Li Y; Zeng L; Lian G; Li J; Chen S; Huang K; Chen Y
    Nanoscale; 2020 Feb; 12(7):4473-4490. PubMed ID: 32031201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
    Lu L; Jie L; Zhou Y; Zhang J; Feng T; Zhu Y; Chen T; Zhu X; Ji J; Wang Z
    Curr Pharm Des; 2023; 29(9):686-696. PubMed ID: 36967466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PEG Chain Length on Relaxometric Properties of Iron Oxide Nanoparticles-Based MRI Contrast Agent.
    Ge J; Li C; Wang N; Zhang R; Afshari MJ; Chen C; Kou D; Zhou D; Wen L; Zeng J; Gao M
    Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles.
    Qian C; Wang Y; Chen Y; Zeng L; Zhang Q; Shuai X; Huang K
    Biomaterials; 2013 Aug; 34(26):6175-84. PubMed ID: 23721794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
    Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
    J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice.
    Zhang W; Liang X; Zhu L; Zhang X; Jin Z; Du Y; Tian J; Xue H
    EBioMedicine; 2022 Jun; 80():104040. PubMed ID: 35525203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
    Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
    Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models.
    Naumenko V; Garanina A; Nikitin A; Vodopyanov S; Vorobyeva N; Tsareva Y; Kunin M; Ilyasov A; Semkina A; Chekhonin V; Abakumov M; Majouga A
    Contrast Media Mol Imaging; 2018; 2018():8264208. PubMed ID: 30344459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
    Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
    Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of T2* Weighted MRI Imaging Sensitivity of U87MG Glioblastoma Cells Using γ-Ray Irradiated Low Molecular Weight Hyaluronic Acid-Conjugated Iron Nanoparticles.
    Huang HM; Wu PH; Chou PC; Hsiao WT; Wang HT; Chiang HP; Lee CM; Wang SH; Hsiao YC
    Int J Nanomedicine; 2021; 16():3789-3802. PubMed ID: 34103915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
    Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
    J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
    Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
    J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Imaging of Lung Cancer with Hyperpolarized
    Kimura A; Utsumi S; Shimokawa A; Nishimori R; Hosoi R; Stewart NJ; Imai H; Fujiwara H
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.